News Column

FOREST LABORATORIES INC FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

January 28, 2014

Item 7.01. Regulation FD Disclosure. To satisfy its obligations under Regulation FD, Forest Laboratories, Inc. (the "Company") is furnishing certain updated information, including information relating to its proposed notes offering. The disclosure is attached hereto as Exhibit 99.1 and incorporated by reference into this Item 7.01. On January 27, 2014 , the Company issued a press release announcing the pricing of $1.8 billion aggregate principal amount of senior unsecured notes, comprised of $1.05 billion aggregate principal amount of its 4.375% senior unsecured notes due 2019 and $750 million aggregate principal amount of its 4.875% senior unsecured notes due 2021. The press release announcing the pricing of the offering is attached hereto as exhibit 99.1, and is incorporated by reference into this Item 7.01. The information set forth in this Item 7.01 is being furnished under Item 7.01 of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section. In addition, this information shall not be incorporated by reference into any registration statement filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Item 9.01 Financial Statements and Exhibits. The following exhibits are filed with this Current Report pursuant to Item 7.01. (d) Exhibits: Exhibit No. Description 99.1 Press Release of Forest Laboratories, Inc. dated January 27, 2014 . 2 --------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools